Literature DB >> 19139426

Up-front use of aromatase inhibitors as adjuvant therapy for breast cancer: the emperor has no clothes.

Bostjan Seruga1, Ian F Tannock.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19139426     DOI： 10.1200/JCO.2008.19.5594

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  16 in total

1.  The impact of an aromatase inhibitor on body composition and gonadal hormone levels in women with breast cancer.

Authors:  G J van Londen; S Perera; K Vujevich; P Rastogi; B Lembersky; A Brufsky; V Vogel; S L Greenspan
Journal:  Breast Cancer Res Treat       Date:  2010-11-03       Impact factor: 4.872

2.  Breast cancer: Tamoxifen--when more might be better.

Authors:  Carlos Caldas; Ian F Tannock
Journal:  Nat Rev Clin Oncol       Date:  2013-02-05       Impact factor: 66.675

3.  Locoregional Recurrence and Survival Rates after Breast-Conserving Surgery and Hormonal Therapy in 70-Year-Old or Older Patients with Stage I or IIA Breast Carcinoma.

Authors:  Aykut Soyder; Serdar Ozbaş; Savaş Koçak
Journal:  Breast Care (Basel)       Date:  2013-05       Impact factor: 2.860

4.  Cost-Benefit Analysis of Endocrine Therapy in the Adjuvant Setting for Postmenopausal Patients with Hormone Receptor-Positive Breast Cancer, Based on Survival Data and Future Prices for Generic Drugs in the Context of the German Health Care System.

Authors:  Michael P Lux; Claudia Reichelt; Jon Karnon; Thorsten D Tänzer; Dragan Radosavac; Peter A Fasching; Matthias W Beckmann; Falk C Thiel
Journal:  Breast Care (Basel)       Date:  2011-10-13       Impact factor: 2.860

5.  Role of aromatase inhibitors in the upfront adjuvant hormonal therapy of postmenopausal patients with breast cancer.

Authors:  Jean-Marc Nabholtz; Marie-Ange Mouret-Reynier; Xavier Durando; Isabelle Van Praag; Béatrice Nayl; Jean-Pierre Ferriere; Philippe Chollet
Journal:  Indian J Surg Oncol       Date:  2010-08-07

Review 6.  Update on the use of aromatase inhibitors in early-stage breast cancer.

Authors:  Georgios Kesisis; Andreas Makris; David Miles
Journal:  Breast Cancer Res       Date:  2009       Impact factor: 6.466

7.  Breast cancer recurrence in older women five to ten years after diagnosis.

Authors:  Jaclyn L F Bosco; Timothy L Lash; Marianne N Prout; Diana S M Buist; Ann M Geiger; Reina Haque; Feifei Wei; Rebecca A Silliman
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-10-20       Impact factor: 4.254

Review 8.  Tamoxifen: the drug that came in from the cold.

Authors:  L Hughes-Davies; C Caldas; G C Wishart
Journal:  Br J Cancer       Date:  2009-08-11       Impact factor: 7.640

9.  Introduction to sessions on guidelines and endocrine therapy, the influence of breast screening on number of mastectomies and the challenge between molecular science and traditional dogma in the treatment of breast cancer. Introduction to Session 6.

Authors:  Gordon C Wishart; Udi Chetty
Journal:  Breast Cancer Res       Date:  2009-12-18       Impact factor: 6.466

10.  Thresholds for therapies: highlights of the St Gallen International Expert Consensus on the primary therapy of early breast cancer 2009.

Authors:  A Goldhirsch; J N Ingle; R D Gelber; A S Coates; B Thürlimann; H-J Senn
Journal:  Ann Oncol       Date:  2009-06-17       Impact factor: 32.976
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.